Company intelligence / Profile preview

Zhongchao

Shanghai, Shanghai, Chinaizcmd.com ↗

Ownership: Public · ZCMD
Development stage: Other

Overview

Zhongchao provides digital healthcare information, professional training, patient management, and pharmaceutical services in China, with a focus on oncology and rare diseases. It operates several online platforms for both healthcare professionals and patients, including partnerships to support medication access for cancer patients[1][3][4].

Therapeutic areas: Rare DiseasesOncology
Industry: Non-Academic Healthcare

Partnerships

Takeda Pharmaceutical Company Limited[6]Beijing Public Health Foundation[4]

Financials

Market cap: $29.4K
Total revenue: $5.8M
Enterprise value: $-13.9M

Beyond the preview

Go deeper on Zhongchao.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongchao.

Explore the full profile